Jon Dobson Email & Phone Number

Washington, Dc, Us

Rockville, Maryland, Us

Leading work across the organization to support ESG strategy development, and to coordinate and implement ESG initiatives.

Rockville, Maryland, Us

Led development and implementation of strategic communications to support USP's efforts to address vulnerabilities in the global medicines supply chain and help ensure availability of quality medicines.

Washington, Dc, Us

Led media relations efforts for the Global, Legal, Payment, and Diagnostics departments of the world’s largest medical technology trade association (representing over 400 leading global manufacturers of medical devices and diagnostics). Served as lead editor and writer of executive presentations, external and internal policy communications, the association’s annual report, policy advocacy materials, press releases, op-eds, talking points, social media, web content, and other stakeholder outreach communications.• Planned and executed key elements of multiple public affairs campaigns, including AdvaMed’s successful effort to repeal the medical device excise tax to save the industry over $2 billion annually• Contributed to issue and crisis communications strategy development, including through creation of media and stakeholder messaging documents and other resources, to bolster the medtech industry’s reputation for providing safe and effective products that save and improve lives• 2020 Gold Circle Award Winner: Best Advocacy Campaign – Medical Device Tax Repeal – awarded to AdvaMed by the American Society of Association Executives• APCO Worldwide TradeMarks Study 2019: AdvaMed ranked first among D.C. trade associations in three of 15 performance categories – Multilateral Impact, Bipartisanship, and Information Resource

Washington, Dc, Us

Served as lead editor and writer of internal and external policy communications, PowerPoint presentations, executive speeches, earned media, public statements, and talking points on key issues. On-record spokesperson for AdvaMed’s Global, Legal, and Payment departments.• Developed key industry messages and supporting proof points on the value of medical technology to patients, health care systems, and the economy, to advance the association’s flagship “Life Changing Innovation” campaign and implementation of government policies supporting medtech innovation• Expanded and updated the design of the association’s annual report to better communicate key policy wins and progress points, and help build and retain association membership• Increased CEO visibility by generating and supporting speech opportunities and earned media placements, and developing compelling PowerPoint presentation materials for diverse audiences ranging from Board members to investors, and from government officials to graduate students

Amsterdam, North Holland, Nl

Led all aspects of production for the market-leading weekly news journal on the medical device and diagnostics industry (“The Gray Sheet” - published by Elsevier Business Intelligence), including hiring, training and overseeing a reporting staff of seven editors and reporters.• Shepherded transition to expanded online and daily production of news and analysis – on FDA regulatory actions, Medicare reimbursement changes, Capitol Hill legislative efforts, and corporate financial and legal issues – to adapt to an accelerated news cycle• Increased contributions of news stories to affiliated EBI publications, including “Health News Daily” and “The Pink Sheet” Daily, to boost editorial efficiency and productivity

Amsterdam, North Holland, Nl

Championed increased focus on pro-active enterprise stories in “The Gray Sheet” (versus reactive news coverage), and those featuring compelling interviews and in-depth analysis, to expand our subscriber base

Amsterdam, North Holland, Nl

Led all aspects of production for the market-leading monthly newsletter on the prescription pharmaceuticals industry, published by Elsevier Business Intelligence, including managing a staff of three reporters and researchers.• Bolstered focus on in-depth news and analysis of pharmaceutical regulatory policy, commercial licensing, scientific data, and R&D pipelines, to expand readership